EGFR and neoplasm: In previous studies, we defined the comprehensive downstream changes upon inhibition of oncogenic EGFR/ErbB2 in EGFR/ErbB2-addicted tumor models and identified a very select number of genes altered as early as 6 hours following EGFR/ErbB2 blockade [29].